Geometry Dash APK Hill Climb Racing APK
36.2 F
New York
Sunday, January 16, 2022

Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) Shares Jump Big After FDA’s Review

Must read

Humbl Inc (OTCMKTS:TSNPD) Bounces Back and Lands On The Radar

Over the course of the past months, Humbl Inc (OTCMKTS:TSNPD) stock has managed to record massive gains and much of that has...

Alpine 4 Technologies Ltd (OTCMKTS:ALPP) Looks to Maintain Critical Momentum

Stocks that make massive gains over a reasonable period of time cannot hope to maintain them forever. At some point, a correction...

Green Thumb Industries Inc (OTCMKTS:GTBIF) Trades Near All-Time High: What Next?

After having been in the dumps for more than a year, the cannabis sector has managed to make a remarkable comeback. Investors...

VIVO Cannabis Inc (OTCMKTS:VVCIF) Stock Turns Volatile: Uptrend in Jeopardy

Anyone watching the market knows the cannabis sector has been booming again. Since the start of the year, the cannabis sector has...

FDA’s intended crackdown on CBD-infused food products is music to Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) investors’ ears.

The agency’s announcement to hold its first public hearing on May 31 on CBD as it explores ways to regulate CBD-infused food products was met with excitement from Zynerba’s investors. The results boosted ZTNE’s stock nearly 20%.

Bullish Trend Persists

The stock’s bullish trend has persisted to the previous day’s business day netting a price of $7.40, an impressive 14.20% jump from the day’s opening price and scoring the company a new valuation of $155.52 million.

Michael Higgins, analysts at Ladenburg is of the opinion that the FDA will be launching a crackdown on all non-prescription products in the market including THC and CBD which will, inturn, grow the market adoption of Zynerba’sZygel.

Zygel is the only patented permeation-enhanced CBD gel that delivers treatment through the skin into the circulation system. Unlike most CBD-based drugs, the gel minimizes effects associated with drugs delivery through the digestive system which include psychoactive effects, effects of drug-drug interaction, and the threat of having the drug ingested by the patient’s liver. The gel is fashioned to treat rare neuropsychiatric conditions like fragile syndrome and autism spectrum disorder.

Analysts’ Favorable Ratings

As such, Higgin has recommended a BUY rating on Zynerba’s stock with an optimistic price target of $26. Oren Livnat of the Five-star HC Wainwright has also given the company’s stock a BUY recommendation and a price target of $23. Livnat went on record saying “We reiterate our Buy, rating and see the current $105M market cap ($27M EV) leaving remarkable upside potential on positive data; as our $23 price target still reflects only a 35% probability of success in FXS.”

With inbound regulation framework seemingly favoring Zynerba, the future could only look bright for the innovative biotech company.


Latest article

iQSTEL Inc (OTCMKTS:IQST) Stock Makes a Big Move: Jumps 45% In a Week

In the past week, iQSTEL Inc (OTCMKTS: IQST) has emerged as a point of focus among a large number of investors and...

HUMBL Inc (OTCMKTS:HMBL) Stock Sees Big Bounce After Recent Slump

Since the beginning of 2021, HUMBL Inc (OTCMKTS:HMBL) had been one of the major movers from among penny stocks and had come into...

Dividend Stocks to Buy Now

A classic mistake that investors make when looking for dividend stocks is to just go for the biggest dividend yield. It makes...

88 Energy Ltd (OTCMKTS:EEENF) Stock Surges 40% But Can’t Hold Gains

The oil and gas company 88 Energy Ltd (OTCMKTS:EEENF) seems to have come back on to the radars of investors over the...

Net Savings Link Inc (OTCMKTS:NSAV) Stock is Getting Pummeled Again

Nowadays there are plenty of options for investors when it comes to making investments in the cryptocurrency and...
Şehirler arası nakliyat ve Şehirler arası taşımacılık konusunda en uygun fiyatlar ve en kaliteli hizmet.
ofis taşıma firmaları ve ofis taşıma konusunda en uygun fiyatlar ve en kaliteli hizmet.
SmsVerifyer.com Affordable best sms verification service